Consensus Cloud Solutions (CCSI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Q4 2024 revenue was $87 million, down 0.9% year-over-year, with adjusted EBITDA of $44.4 million and adjusted EPS of $1.32, up 18.9% year-over-year.
FY2024 revenue declined 3.4% to $350.4 million, while adjusted EBITDA rose 1% to $188.4 million and adjusted EPS increased 10.6% to $5.63.
Corporate segment growth offset expected SoHo declines, with all key metrics finishing at the higher end of guidance.
Free cash flow reached a record $88.3 million for 2024, up 13.7% from 2023.
Significant reduction in outstanding debt and continued share repurchases.
Financial highlights
Q4 adjusted EBITDA margin was 51.0%; FY2024 margin was 53.8%.
Q4 net income was $25.8 million, up 20.8% year-over-year; full-year net income was $89.4 million, up 15.7%.
Q4 free cash flow was $3.1 million, a turnaround from -$5.7 million in Q4'23.
Q4'24 capex was $8 million; FY2024 capex was $33.4 million, 8% lower than 2023.
Ended 2024 with $34 million in cash.
Outlook and guidance
FY2025 revenue guidance: $343–$357 million; adjusted EBITDA: $179–$190 million; adjusted EPS: $5.03–$5.42.
Q1 2025 revenue guidance: $85–$89 million; adjusted EBITDA: $44.8–$47.8 million; adjusted EPS: $1.26–$1.36.
Corporate revenue expected to grow 4.5%–8.5% in 2025; SoHo revenue to decline 7.5%–11.5%.
Adjusted EBITDA margin guidance for 2025: 52.2%–53.2%.
Corporate revenue expected to grow 6–6.5% in 2025; SoHo revenue to decline 9.5%.
Latest events from Consensus Cloud Solutions
- Corporate growth, record cash flow, and debt reduction drive a strong 2026 outlook.CCSI
Q4 202510 Feb 2026 - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower revenue, with improved guidance for the year.CCSI
Q2 20241 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue fell 3.1% but margin gains and debt reduction supported strong corporate growth.CCSI
Q3 202415 Jan 2026 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, auditor, and executive pay, all board-recommended.CCSI
Proxy Filing2 Dec 2025 - Q1 2025 revenue down 1.1%, Corporate growth offsets SoHo decline; guidance reaffirmed.CCSI
Q1 202525 Nov 2025 - Corporate revenue up 6.9% year-over-year, driving first total revenue growth in eight quarters.CCSI
Q2 202523 Nov 2025